Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Inotiv stock
Learn how to easily invest in Inotiv stock.
Inotiv Inc is a diagnostics & research business based in the US. Inotiv shares (NOTV) are listed on the NASDAQ and all prices are listed in US Dollars. Inotiv employs 541 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Inotiv
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NOTV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Inotiv stock price (NASDAQ: NOTV)Use our graph to track the performance of NOTV stocks over time.
Inotiv shares at a glance
|Latest market close||$30.71|
|52-week range||$11.21 - $60.66|
|50-day moving average||$46.08|
|200-day moving average||$33.18|
|Wall St. target price||$65.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.19|
Buy Inotiv shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Inotiv stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Inotiv price performance over time
|1 week (2022-01-13)||-4.51%|
|1 month (2021-12-20)||-22.92%|
|3 months (2021-10-20)||-7.50%|
|6 months (2021-07-20)||8.10%|
|1 year (2021-01-20)||106.52%|
|2 years (2020-01-17)||408.44%|
|3 years (2019-01-18)||2,062.68%|
|5 years (2017-01-20)||3,167.37%|
Is Inotiv stock undervalued or overvalued?
Valuing Inotiv stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inotiv's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inotiv's P/E ratio
Inotiv's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 177x. In other words, Inotiv shares trade at around 177x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Inotiv's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 million.
The EBITDA is a measure of a Inotiv's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$89.6 million|
|Gross profit TTM||$30.2 million|
|Return on assets TTM||-1.42%|
|Return on equity TTM||19.33%|
|Market capitalisation||$811.5 million|
TTM: trailing 12 months
Inotiv share dividends
We're not expecting Inotiv to pay a dividend over the next 12 months.
Inotiv share price volatility
Over the last 12 months, Inotiv's shares have ranged in value from as little as $11.21 up to $60.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inotiv's is 2.0512. This would suggest that Inotiv's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally.
Inotiv in the news
Monument Capital Management Buys SPDR Bloomberg 1-3 Month T-Bill ETF, iShares Core S&P ...
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Inotiv : Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC - Form 8-K
Frequently asked questionsWhat percentage of Inotiv is owned by insiders or institutions?
Currently 33.389% of Inotiv shares are held by insiders and 51.012% by institutions. How many people work for Inotiv?
Latest data suggests 541 work at Inotiv. When does the fiscal year end for Inotiv?
Inotiv's fiscal year ends in September. Where is Inotiv based?
Inotiv's address is: 2701 Kent Avenue, West Lafayette, IN, United States, 47906 What is Inotiv's ISIN number?
Inotiv's international securities identification number is: US45783Q1004
More guides on Finder
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert